Leveraging Functional Service Providers for Enhanced Efficiency in Drug Development

Life Sciences, Clinical Trials, Drug Discovery & Development,
  • Thursday, October 31, 2024

Discover an informative webinar to learn how functional service providers (FSPs) are transforming the clinical research landscape by providing specialized skills, adaptable resources and cost-efficient solutions.

As drug development costs continue to escalate, sponsors need to find less expensive approaches to develop their assets. One way to be more cost-efficient is to outsource some areas of drug development. FSPs have reshaped clinical research by offering specialized skills and adaptable resources.

As trials become more complex, many biotech and biopharma companies are opting for FSPs over full-service outsourcing. FSPs provide numerous advantages such as globalized strategies, expert domain knowledge and efficient management, thus helping balance quality, innovation and cost.

Sponsors engage FSP models when seeking efficiencies. FSP models provide increased operational and resourcing flexibility and different pricing plans in comparison to traditional full-service clinical research organization (CRO) offerings. FSPs deliver capabilities across a broad base, including subject matter experts in the functional areas, which helps accelerate drug development and decrease overall costs.

A sponsor should feel a true partnership with an adaptable provider willing to help achieve high-quality, cost-effective results as clinical trials are becoming complex and require specific expertise.

Register for this webinar today to learn about the strategic advantages, including expert domain knowledge, global strategies and operational flexibility, for biotech and biopharma companies in engaging functional service providers for drug development.

Speakers

Melissa Church, Catalyst Clinical Research

(Moderator) Melissa Church, SVP, Strategy & Solutions, Catalyst Clinical Research

Melissa Church has over 25 years of sales, operations and strategy development experience across multiple industries including clinical research, healthcare consulting and technology, and health insurance. Melissa started her professional career with ClinTrials Research before moving to SAS Institute where she worked for six years leading business development and proposal functions.

Her most recent clinical research experience includes nearly three years leading the contracts and proposal development function at PPD. Here she created the first strategic finance team focused on developing innovative pricing models to support client partnerships. After PPD, Melissa moved to UnitedHealth Group where she first worked for Optum and led their Sales Operations division.

Read more...

She also sat on the acquisition integration team and supported the integration of multiple small- to medium-sized businesses. In her last four years at UnitedHealth Group, Melissa led sales operations for the Medicaid business unit and held operational leadership roles.

Read Less...

Message Presenter
Craig McIlloney, Catalyst Clinical Research (Flex)

Craig McIlloney, SVP, Catalyst Flex, Catalyst Clinical Research

Craig McIlloney brings 25 years of experience in drug development with small and large CROs to his role with Catalyst. As Senior Vice President of Catalyst Flex, Craig is responsible for the global execution of functional services across multiple therapeutic areas.

In his previous roles, Craig has overseen global operations across multiple functions, including but not limited to data management, biostatistics, statistical programming, medical writing, quality, analytics, systems and communications. This has included global expansion across multiple regions and his leadership experience spans activities across various delivery models, including FSP, full-service and hybrid models.

Read more...

He earned a BS (Hons) in Statistics from the University of Glasgow, UK, and an MS in Applied Statistics from Napier University, Edinburgh, UK. He is a Chartered Statistician (Cstat) with the Royal Statistical Society and was previously a Director of the Statisticians in the Pharmaceutical Industry (PSI).

Read Less...

Message Presenter
Rob Petrie, CIO, OrciMed Life Sciences

Rob Petrie, Chief Innovation Officer, OrciMed Life Sciences

Rob Petrie has more than 30 years of industry experience working in clinical research. Working as the CIO, Rob is responsible for all technology and innovation strategies that drive efficiency and quality operations within OrciMed and for directly supporting our customers’ needs.

Rob started his career working at Life Science Research in the UK. He then transferred to the USA managing IT teams in the Pharmaco Phase 1 Clinic, BioAnalyical, GMP and Central Lab groups. Rob took the lead IT role at PPD as Chief Technology Officer in 2015 providing technology strategy, innovation and services across the 33,000-person global organization. Rob was responsible for managing a large technology organization of more than 700 global technology staff across five continents.

Rob has extensive experience building high performing offshore labor centers in Eastern Europe and Asia/Pacific.

Message Presenter
Elisha Talley-Roithner, Launch Therapeutics

Elisha Talley-Roithner, Head of Operations, Launch Therapeutics

Elisha has over 25 years of drug development experience. Elisha spent the last 14 years at PPD where she was most recently, Head of Development Operations. In this role, she had global accountability for a $3.5B clinical trial portfolio. Elisha is recognized for generating and implementing innovative, strategic solutions. She is a founding member of PPD Biotech and led the creation and implementation of an industry-leading Biotech operating model which resulted in improved project cycle times and significant business expansion. Before PPD, Elisha led the Infectious Disease and Biotech project management teams at Covance (now Fortrea).

Message Presenter

Who Should Attend?

This webinar will appeal to Director level and above in the following fields:

  • Clinical operations
  • Data science, biometrics and data management, biostatistics, programming
  • Site clinical trial staff
  • Procurement/outsourcing
  • Project management
  • Medical writing
  • PVG/safety

What You Will Learn

Attendees will learn about:

  • What makes an adaptable FSP solution essential for sponsors and large CROs
  • Why is flexibility a key characteristic of successful clinical trials and for functional engagements
  • What should be considered when deciding the functional model and the provider
  • How to identify a trusted partner for clinical research

Xtalks Partner

Catalyst Clinical Research

Catalyst Flex, a solution of Catalyst Clinical Research, provides global functional services delivered by experts in clinical operations, data management, biostatistics and programming, safety and pharmacovigilance, and medical writing for the biopharmaceutical and biotechnology industries. As a functional service provider (FSP), Catalyst Flex supplies people, process, and technology solutions designed to meet each client’s unique clinical trial needs. Catalyst Flex’s flexible service model comes from more than a decade of listening to customers, devising customer-centric solutions, and helping customers advance clinical studies by leveraging expert teams and innovative technologies.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account